medica innovatica   
  • International Standard Serial Number: (p)-ISSN : 2278-7526, (e)-2320-7582

  • Medica Innovatica is an open access, biannual peer-reviewed indexed medical journal published in January and July of every year by B.V.V. Sangha’s S. Nijalingappa Medical College, Bagalkot, Karnataka, India. The journal publishes original articles, review articles, case studies and brief communication in anatomy, physiology, biochemistry, pathology, pharmacology, microbiology, forensic medicine, community medicine, oto-rhino-laryngology, ophthalmology, medicine, surgery, obstetrics & gynaecology, orthopedics, pediatrics, anesthesia, dermatology, radiology, psychiatry and all the related fields of medical and health sciences, with special preference to those whose implications are directed towards improving the health care of the community, directly or indirectly. Journal enkindles the spark of innovation which is basic instinct embodied in every human being and the creativity needs proper galvanization and channelization.

    Publication Ethics:

    The editorial board of Medica Innovatica is committed to meeting and upholding ethical standards of publication process. We follow publication ethics and scientific conduct as per COPE guidelines (Committee On Publication Ethics - UK) (, International Committee of Medical Journal Editors ( e.html) and World association of medical editors –WAME ( policie). The act of publishing involves many parties, each of which plays an important role in achieving these aims. The author, the journal editor, the peer reviewer and the publisher have responsibilities to meet expected ethical standards at all stages in their involvem ent from submission to publication of an article.
    Ethical expectations are summarized below:
    Editors' responsibilities
  • Expected duties should be carried out without discrimination on grounds of gender, religious or political beliefs, ethnic or geographical origin of the authors.
  • Special issues should be handled in the same way as other submissions, so that articles are considered and accepted solely on their academic merit and without commercial influence.
  • Reasonable procedures should be followed in the event of complaints of an ethical or conflict nature, authors should be given a reasonable opportunity to respond to any complaints, complaints should be investigated no matter when the original publication was approved and documentation associated with any such complaints should be retained.
  • Reviewers' responsibilities
  • Reviewers should contribute to the decision-making process, and assist in improving the quality of the published paper by reviewing the manuscript objectively, in a timely manner.
  • They should maintain confidentiality of any information supplied by the editor or author ; and should not retain or copy the manuscript.
  • They should alert the editor to any published or submitted content that is substantially similar to that under review.
  • They should be aware of any potential conflicts of interest (financial, institutional, collaborative or other relationships between the reviewer and author) and alert the editor to these, if necessary withdraw their services for that manuscript.
  • Authors' responsibilities
  • Authors should maintain accurate records of data associated with their submitted manuscript, and provide access to these data, on request..
  • They should confirm that the manuscript as submitted is not under consideration or accepted for publication elsewhere. In places where portions of the content overlap with published or submitted content, they should acknowledge and cite those sources. Additionally, they should provide the editor with a copy of any submitted manuscript that might contain overlapping or closely related content.
  • They should confirm that all the work in the submitted manuscript is original and acknowledge and cite content reproduced from other sources. They should obtain permission to reproduce any content from other sources.
  • Authors should ensure that any studies involving human or animal subjects conform to national, local and institutional laws and requirements (e.g. WMA Declaration of Helsinki, NIH Policy on Use of Laboratory Animals, EU Directive on Use of Animals) and confirm that approval has been sought and obtained where appropriate. Authors should obtain permission from human subjects and respect their privacy.
  • They should declare any potential conflicts of interest (e.g. where the author has a competing interest (real or apparent) that could be considered or viewed as exerting an undue influence on his or her duties at any stage during the publication process).
  • They should notify promptly the journal editor or publisher if a significant error in their publication is identified. To cooperate with the editor and publisher to publish an erratum, addendum, corrigendum notice, or to retract the paper, where this is deemed necessary.
  • Publisher responsibilities
  • Publisher shall ensure that good practice is maintained to the standards outlined above.
  • Procedures for dealing with unethical behaviour
    Identification of unethical behaviour
  • Misconduct and unethical behaviour will be identified and brought to the attention of the editor and publisher at any time, by anyone.
  • Misconduct and unethical behaviour may include, but need not be limited to, failure of adhering to the ethical practices as outlined above.
  • Whoever informs the editor or publisher of such conduct should provide sufficient information and evidence in order for an investigation to be initiated. All allegations will be taken seriously and treated in the same way, until a successful decision or co nclusion is reached.
  • Investigation
  • An initial decision will be taken by the editor, who will consult with the publisher and the members of the editorial board.
  • Evidence will be gathered, while avoiding spreading any allegations beyond those who need to know.
  • Minor breaches
  • Minor misconduct will be dealt with, without the need to consult more widely. In any event, the author will be given the opportunity to respond to any allegations.
  • Serious breaches
  • Serious misconduct might require that the employers of the accused be notified. The editor, in consultation with the publisher, will make the decision whether or not to involve the employers, either by examining the available evidence themselves or by further consultation with a limited number of experts.
  • Outcomes (in increasing order of severity; will be applied separately or in conjunction)
  • Informing the author or reviewer where there appears to be a misunderstanding or misapplication of acceptable standards.
  • Letter to the author or reviewer covering the misconduct and as a warning for future behaviour.
  • Publication of a formal notice detailing the misconduct.
  • Publication of an editorial detailing the misconduct.
  • A formal letter to the head of the author's or reviewer's department or funding agency.
  • Formal retraction or withdrawal of a publication from the journal, in conjunction with informing the head of the author or reviewer's department, Abstracting & Indexing services and the readership of the publication.
  • Imposition of a formal embargo on contributions from an individual for a defined period.
  • Reporting the case and outcome to a professional organisation or higher authority for further investigation and action.
  • Redundant or duplicate publications: A manuscript will be reviewed for possible publication with the understanding that it is being submitted to Medica Innovatica alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. Authors found to have redundant or duplicate publications will not be considered for publication in our journal for a period of 2 years.
    Originality: Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review.
    Plagiarism: Manuscripts will also undergo a plagiarism check and authors with plagiarized manuscripts will be asked to give explanation for the same and the same will be rejected.
    Review process: All manuscripts received are duly acknowledged. On submission, editors review all submitted manuscripts. Manuscripts that are found suitable for publication in Medica Innovatica are sent to two or more expert reviewers. The journal follows a double-blind review process, where in the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/rejection/revision in manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within two days. The whole process of submission of the manuscript to final decision; sending and receiving proofs is completed online, with an average of 6 weeks duration.
    Authorship Criteria: Authorship credit should be based only on substantial contributions to each of the three components mentioned below: 1. Concept and design of study or acquisition of data or anal ysis and interpretation of data; 2. Drafting the article or revising it critically for important intellectual content; and 3. Final approval of the version to be published. Every manuscript should be accompanied by a contributor’s form which describes about the contribution of each author towards the manuscript, with respect to the above authorship criteria. The originality of the manuscript has to be declared by the authors.
    Licence information: All articles in Medica Innovatica are published under an Open Access license that allows free download and redistribution. All other rights remain with the journal. Users can use, reuse and build upon the material published in the journal but only for non - commercial purposes.
    Open access statement: This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any othe r lawful purpose, without asking prior permission from the publisher or the author.
    Preparation of the manuscript: Manuscripts should be prepared in concordance with the Uniform requirements for manuscripts submitted to biomedical journals formulated by the International Committee of Medical Journal Editors ( e.html ). For more details, look for instructions to authors ( .pdf).

    Subscription Information:

    Annual subscription rate

    - Personal : Rs. 1000/- Within India

    USD.100/- Outside India

    Institutional: Rs. 3000/- Within India

    USD. 200/- Outside India


    The Editorial board of Medica Innovatica disclaims any responsibility for statements made and opinions expressed by authors or claims made by advertisers


    No part of this journal may be reproduced or transmitted in any form or by any means, electronic or print including photocopying without written permission from Editor-in-Chief / Publisher. © All rights reserved.


    Dr. Ashok.S. Mallapur
    Professor, Department of Surgery
    S Nijalingappa Medical College and H.S.K. Hospital and Research Centre
    Bagalkot - 587102 Karnataka, India.
    Phone No:08354-235360 Fax. No:08354-235360

    Address for Correspondence:

    Dr. Anita. Herur
    Professor, Dept of Physiology,
    Editor in chief, Medica Innovatica Journal Office,
    S Nijalingappa Medical College and H.S.K. Hospital and Research Centre
    Bagalkot - 587102
    Karnataka, India.